Five microRNAs in Serum Are Able to Differentiate Breast Cancer Patients From Healthy Individuals.
breast cancer
diagnosis
microRNAs
prognosis
serum
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2020
2020
Historique:
received:
22
07
2020
accepted:
17
09
2020
entrez:
23
11
2020
pubmed:
24
11
2020
medline:
24
11
2020
Statut:
epublish
Résumé
Breast cancer is the cancer with the most incidence and mortality in women. microRNAs are emerging as novel prognosis/diagnostic tools. Our aim was to identify a serum microRNA signature useful to predict cancer development. We focused on studying the expression levels of 30 microRNAs in the serum of 96 breast cancer patients
Identifiants
pubmed: 33224883
doi: 10.3389/fonc.2020.586268
pmc: PMC7670964
doi:
Types de publication
Journal Article
Langues
eng
Pagination
586268Informations de copyright
Copyright © 2020 Feliciano, González, Garcia-Mayea, Mir, Artola, Barragán, Martín, Altés, Castellvi, Benavente, Ramón y Cajal, Espinosa-Bravo, Cortés, Rubio and LLeonart.
Références
Mol Aspects Med. 2019 Dec;70:57-71
pubmed: 31558294
Breast Cancer Res. 2019 Feb 6;21(1):21
pubmed: 30728048
Nucleic Acids Res. 2014;42(17):e133
pubmed: 25063298
PLoS One. 2012;7(4):e34210
pubmed: 22523546
BMC Cancer. 2014 Jun 18;14:448
pubmed: 24938880
Carcinogenesis. 2016 May;37(5):461-70
pubmed: 26785733
Proteomics Clin Appl. 2019 May;13(3):e1700119
pubmed: 30281209
Clin Chem. 2015 Aug;61(8):1098-106
pubmed: 26056355
J Natl Cancer Inst. 2016 Apr 13;108(8):
pubmed: 27075851
Biomed Pharmacother. 2008 Feb;62(2):130-5
pubmed: 17728092
Oncotarget. 2018 Apr 27;9(32):22523-22536
pubmed: 29854296
J Pathol. 2016 Oct;240(2):235-45
pubmed: 27447723
J Diabetes Res. 2018 Apr 29;2018:6165303
pubmed: 29854824
Biochem Biophys Res Commun. 2014 Nov 7;454(1):210-4
pubmed: 25450382
Breast. 2016 Oct;29:181-5
pubmed: 27544822
J Hematol Oncol. 2018 May 10;11(1):64
pubmed: 29747682
CA Cancer J Clin. 2017 Nov;67(6):439-448
pubmed: 28972651
J Breast Cancer. 2018 Dec;21(4):363-370
pubmed: 30607157
Front Genet. 2013 Jun 21;4:116
pubmed: 23802013
J Cancer. 2018 Sep 8;9(20):3728-3735
pubmed: 30405844
Oncotarget. 2016 Dec 27;7(52):86457-86468
pubmed: 27833082
EBioMedicine. 2016 Sep;11:199-209
pubmed: 27566954
J Cell Physiol. 2019 Nov;234(11):19199-19211
pubmed: 31026062
Clin Cancer Res. 2013 Aug 15;19(16):4477-87
pubmed: 23797906
Oncotarget. 2016 Aug 23;7(34):55231-55248
pubmed: 27409424
Cancers (Basel). 2019 Jun 27;11(7):
pubmed: 31252695
Nature. 2005 Jun 9;435(7043):834-8
pubmed: 15944708
Clin Cancer Res. 2015 Mar 1;21(5):1207-14
pubmed: 25547678
Cancer Res. 2011 May 15;71(10):3552-62
pubmed: 21444677
PLoS One. 2013 Oct 03;8(10):e76247
pubmed: 24098452
PLoS One. 2013;8(1):e54213
pubmed: 23372687
Oncol Rep. 2017 Jun;37(6):3297-3304
pubmed: 28440475
PLoS One. 2010 Oct 20;5(10):e13515
pubmed: 20976003
Hum Pathol. 2017 Jun;64:44-52
pubmed: 28412211
Cancer Immunol Immunother. 2019 Jan;68(1):57-70
pubmed: 30276443
Cell Death Dis. 2017 Oct 26;8(10):e3141
pubmed: 29072692
Ann Surg Oncol. 2019 Feb;26(2):366-371
pubmed: 30542840
Br J Cancer. 2015 May 26;112(11):1751-9
pubmed: 25906045
BMC Genomics. 2019 Jun 17;20(1):503
pubmed: 31208318
Neural Comput. 1999 Aug 15;11(6):1427-53
pubmed: 10423502
Clin Chem. 2013 Oct;59(10):1489-96
pubmed: 23748853